Elanco names Bob VanHimbergen CFO, succeeding Todd Young; guidance reconfirmed
Elanco Animal Health appointed Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025, succeeding Todd Young, who stays on as an advisor through August 31, 2025. The company also reconfirmed its second quarter and full year guidance issued on May 7, 2025.
Key points
- VanHimbergen, age 49, is currently CFO of Hillenbrand, Inc. and previously spent about 15 years at Johnson Controls International plc.
- Initial pay includes a $660,000 base salary, a target annual cash incentive of 75% of base salary, and target long-term incentive compensation of $2,645,000.
- Make-whole awards include a $890,000 cash bonus subject to partial repayment if he leaves within three years, and restricted stock units with a grant fair value of $1,735,000.
- Young's transition terms include continued pay for his advisory role and accelerated vesting of a pro-rata portion of his unvested awards.
The filing
Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 28, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.